U.S. Markets close in 2 hrs 47 mins

Amicus Therapeutics' wound treatment fails late-stage trial

Sept 13 (Reuters) - U.S. drug developer Amicus Therapeutics Inc said on Wednesday its drug to treat wounds failed to meet the main goals of a late-stage clinical trial.

The company said its drug, when compared with a placebo, did not show a statistical significance in reducing the time taken for wounds to close in patients with epidermolysis bullosa, a skin disease that causes blisters. (Reporting by Manas Mishra in Bengaluru; Editing by Sai Sachin Ravikumar)